The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Phase II data of brigantinib for relapsed and metastatic NSCLC released
Data from the pivotal Phase 2 ALTA clinical trial evaluating brigatinib in patients with crizotinib-refractory, anaplastic lymphoma…